Stay updated on Durvalumab with Chemoradiation in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab with Chemoradiation in Lung Cancer Clinical Trial page.

Latest updates to the Durvalumab with Chemoradiation in Lung Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe study history now shows a new latest revision (v3.6.5) and removes the previous revision (v3.6.4), updating the record's revision log to reflect the latest changes.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe study history shows a new revision entry (v3.6.4) that supersedes the earlier v3.6.3, reflecting an update to the record.SummaryDifference0.1%

- Check30 days agoChange DetectedVersion history shows the study status updated to Completed with a corresponding recruitment status change. This indicates that enrollment has ended and the trial has concluded.SummaryDifference0.4%

- Check44 days agoChange DetectedA new revision, v3.6.3, appears in the record history, indicating the latest update to the study page. This revision is metadata about the page version and does not modify the study data or content.SummaryDifference0.1%

- Check51 days agoChange DetectedA new revision entry v3.6.2 was added to the record history. The older revision v3.6.0 was removed from the history.SummaryDifference0.1%

- Check66 days agoChange DetectedRecruitment status updated to not recruiting participants, signaling the study is not enrolling any longer. The version history shows a new revision (v3.6.0) replacing the previous v3.5.5.SummaryDifference0.3%

Stay in the know with updates to Durvalumab with Chemoradiation in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab with Chemoradiation in Lung Cancer Clinical Trial page.